United Therapeutics | UTHR - Koszty Sprzedaży I Administracji





Koszty Sprzedaży I Administracji Zmiana Data
Amarin USD 18.97M 1.03M 2025-12
Ardelyx USD 75.92M 7.69M 2025-12
Baxter International USD 761M 53M 2025-12
Bayer EUR 4.05B 647M 2025-12
BioCryst Pharmaceuticals USD 95.78M 12.77M 2025-12
Biogen USD 545.2M 38.6M 2025-09
BioMarin Pharmaceutical USD 322.21M 98.79M 2025-12
Emergent BioSolutions USD 182.8M 82.3M 2023-06
Esperion Therapeutics USD 39.42M 456K 2025-12
Gilead Sciences USD 1.78B 425M 2025-12
GlaxoSmithKline GBP 2.68B 518M 2025-12
Halozyme Therapeutics USD 64.64M 27.11M 2025-12
Insmed USD 212.48M 26.11M 2025-12
Ionis Pharmaceuticals USD 130M 43.43M 2025-12
J&J USD 6.75B 831M 2025-12
Lexicon Pharmaceuticals USD 3.98M 195K 2025-12
Moderna USD 308M 40M 2025-12
Omeros USD 11.32M 2.48M 2024-09
Pfizer USD 4.08B 894M 2025-12
PTC Therapeutics USD 87.2M 3.15M 2025-12
Regeneron Pharmaceuticals USD 775M 117.2M 2025-12
Sangamo BioSciences USD 9.64M 1.83M 2024-06
Sarepta Therapeutics USD 105.38M 28.27M 2025-12
Teva Pharmaceutical Industries USD 1.12B 147M 2025-12
United Therapeutics USD 190.6M 38.6M 2025-12
Vertex Pharmaceuticals USD 487M 41.9M 2025-12